FDAnews
www.fdanews.com/articles/188999-rps-diagnostics-gains-updated-ce-mark-for-rpc-test
ClearanceStamp_Blue.gif

RPS Diagnostics Gains Updated CE Mark for RPC Test

October 31, 2018

RPS Diagnostics’ FebriDx, a rapid point-of-care test, has received an updated CE Mark, clearing it for launch in the EU.

The diagnostic test allows for a 10-minute assessment of the patient’s immune response to an acute respiratory infection by analyzing a fingerstick blood sample.

The single-use device points out underlying, clinically significant infections in patients and determines if they are bacterial or viral.

View today's stories